ASK3 antibodies target the mitogen-activated protein kinase kinase kinase 15 (MAP3K15), a 147.4 kDa protein with 1,313 amino acids and three isoforms . These antibodies enable:
Detection of ASK3 in biological samples via Western blot (WB), ELISA, and immunohistochemistry (IHC) .
Investigation of ASK3's role in protein phosphorylation and stress-response pathways .
Commercial Availability
Nine ASK3 antibody products are available across suppliers like MyBioSource.com, with applications spanning WB, ELISA, flow cytometry (FCM), and IHC . A subset is highlighted below:
| Product Name | Applications | Reactivity | Supplier |
|---|---|---|---|
| MAP3K15 Antibody (N-term) | WB, ELISA, FCM, IHC | Human, Mouse | MyBioSource.com |
ASK3 bidirectionally responds to osmotic stress (hypotonic and hypertonic conditions) and suppresses the WNK1-SPAK/OSR1 signaling pathway in renal tubules .
Mechanism: ASK3 inhibits WNK1 kinase activity, reducing phosphorylation of SPAK/OSR1 and downstream Na⁺-Cl⁻ cotransporter (NCC) activation .
Phenotypic Evidence:
Under hyperosmotic stress, the 19S proteasome subunit PSMC2 negatively regulates ASK3 activity.
Experimental Validation:
ASK3 antibodies are pivotal in advanced experimental techniques:
Immunofluorescence-Based Activity Assays: Quantify ASK3 activation using phospho-specific antibodies (e.g., Thr808 phosphorylation) .
High-Content Screening: Genome-wide siRNA screens coupled with ASK3 antibody staining identify proteasomal regulators of ASK3 .
The interplay between ASK3 and the WNK1-SPAK/OSR1 pathway offers therapeutic targets for hypertension. ASK3 antibodies facilitate:
Here’s a structured FAQ for ASK3 antibody research, synthesized from peer-reviewed studies and technical guidelines:
Functional Assays:
Kinase Activity: Measure ATP consumption or Syntide 2 phosphorylation in vitro .
Osmotic Stress Models: Expose renal tubular cells to hypertonic media and monitor ASK3-WNK1-SPAK/OSR1 pathway activation via phospho-specific antibodies .
Apoptosis Assays: Use TNF-α or anti-Fas antibody treatments in ASK3 knockdown HeLa cells .
Sequence Alignment: Compare ASK3 epitopes with homologous proteins (e.g., ASK1/ASK2) to identify unique regions .
Peptide Blocking: Preincubate antibodies with excess immunizing peptide to confirm signal specificity .
Native Conditions: Use non-denaturing lysis buffers (e.g., 1% NP-40) to preserve protein interactions .
Protease Inhibition: Include phosphatase inhibitors to maintain phosphorylation states (critical for ASK3-WNK1 binding studies) .